Published in Aliment Pharmacol Ther on December 01, 1998
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol (2000) 3.82
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol (2001) 3.56
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest (2000) 3.47
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology (2001) 2.69
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 2.61
Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol (2001) 2.44
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.25
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
[Sadistic fetishism--deadly passion. Forensic psychiatric assessment of sex offenders]. Nervenarzt (2008) 2.02
Gastric inhibitory action of H2-antagonists ranitidine and cimetidine. Lancet (1979) 2.01
Carbon dioxide insufflation improves intubation depth in double-balloon enteroscopy: a randomized, controlled, double-blind trial. Endoscopy (2007) 1.98
Spontaneous flow of bile through the human pancreatic duct in the absence of pancreatitis: nature's human experiment. Endoscopy (2003) 1.95
Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine. Gastroenterology (1980) 1.93
Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83
Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother (1999) 1.80
Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch (1998) 1.79
Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology (2000) 1.76
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology (1992) 1.70
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol (2001) 1.67
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity. Proc Natl Acad Sci U S A (1969) 1.61
Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60
Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59
Single- vs. double-balloon enteroscopy in small-bowel diagnostics: a randomized multicenter trial. Endoscopy (2011) 1.59
Chemical and Physical Characterization of Interfacial-Active Lipids from Rhodococcus erythropolis Grown on n-Alkanes. Appl Environ Microbiol (1982) 1.57
Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion (2002) 1.51
Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy (1999) 1.51
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer (2000) 1.46
Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer (2011) 1.46
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis (2000) 1.45
Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol (2000) 1.44
Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin. Crit Care Med (2001) 1.43
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2000) 1.40
Mechanical lithotripsy of bile duct stones in 209 patients--effect of technical advances. Endoscopy (1988) 1.39
Cholangiofibromatosis associated with portal hypertension. Am J Gastroenterol (1994) 1.39
Intracoronary thrombi in stable angina: observations with angioscopy. Catheter Cardiovasc Interv (2000) 1.39
Effects of 13-nle-motilin in man--inhibition of gastric evacuation and stimulation of pepsin secretion. Scand J Gastroenterol (1975) 1.35
Failure of an automated blood culture system to detect nonfermentative gram-negative bacteria. J Clin Microbiol (2000) 1.33
In vivo characterization of the Saccharomyces cerevisiae centromere DNA element I, a binding site for the helix-loop-helix protein CPF1. Mol Cell Biol (1991) 1.33
Preoperative diagnosis of bile duct strictures--comparison of intraductal ultrasonography with conventional endosonography. Scand J Gastroenterol (2000) 1.31
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 1.31
Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect Immun (2001) 1.31
Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother (2005) 1.31
New histamine H2-receptor antagonists. Hepatogastroenterology (1980) 1.30
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1995) 1.30
Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28
The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26
Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion (1995) 1.25
Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24
Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins. Antimicrob Agents Chemother (2000) 1.21
Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin. Eur J Clin Microbiol Infect Dis (2005) 1.21
Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20
Late pulmonary metastasis in uterine PEComa. J Clin Pathol (2003) 1.20
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
Plasma secretin and pancreatic bicarbonate response to exogenous secretin in man. Gut (1977) 1.19
Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology (2001) 1.19
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer (1997) 1.18
Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis (2005) 1.17
Epidemiology of Whipple's disease in Germany. Analysis of 110 patients diagnosed in 1965-95. Scand J Gastroenterol (1997) 1.16
Motilin-induced electrical activity in the canine gastrointestinal tract. Scand J Gastroenterol Suppl (1976) 1.15
Tumors of the papilla of Vater--inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol (1999) 1.15
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. J Physiol Pharmacol (1997) 1.15
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol (1999) 1.14
Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol (2001) 1.14
Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects. Gut (1994) 1.13
Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut (1997) 1.13
Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation (2000) 1.12
Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat, and human alimentary tract in vitro. Gastroenterology (1975) 1.11
Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J Natl Cancer Inst (1999) 1.11
Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch (1996) 1.10
Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol (1997) 1.10
Release of motilin after duodenal acidification. Lancet (1976) 1.10
Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy (2002) 1.10
Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch (1997) 1.10
Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10
Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut (1978) 1.09
Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1996) 1.09
[Piezoelectric lithotripsy of gallstones. Initial clinical experiences]. Dtsch Med Wochenschr (1988) 1.08
Exocrine pancreatic function in juvenile diabetics. Am J Dig Dis (1975) 1.08